2020 General Assembly + Immunotherapy

 

15th February 2020

KU Leuven, Herestraat 49,
campus Gasthuisberg
Onderwijs & Navorsing 2 (O&N2) building,
auditorium BMW2.
Parking “Villa”: Entrance code 3404#

Registration Deadline: February 7, 2020

RIZIV/INAMI: activity number: 19057854; 2,5 credits (category: general)

FANC/AFCN:

· 02h00 for NM physicians (NM)


 

CALL FOR BELNUC BOARD CANDIDATES IS OPEN

The positions available in BELNUC board are:

  • The next BELNUC President Elect 2020-2021 (President 2022-2023)
  • The next BELNUC General Secretary Elect 2020-2021 (GenSec 2022-2023)
  • One board member 2020-2022 (physician or physicist)

Candidates for the Technologists section are also welcome.

Application instructions:

Please send your application letter and CV by email to office@belnuc.be

The application deadline is January 15, 2020

Programme

09:00 – 09:45
2020 BELNUC GENERAL ASSEMBLY

 AGENDA

  1. 2019 Accounts
  2. 2019 membership
  3. Bank accounts statements
  4. BELNUC administration
  5. BELNUC services
  6. BELNUC 2019 activities
  7. BELNUC workgroups
  8. BARR section
  9. Technologists section
  10. 2020 and 2021 membership fees to be approved
  11. 2020 Budget
  12. Board members discharge: Karolien Goffin, Nadia Withofs and Pieter De Bondt
  13. Presentation of board members candidates
  14. Voting

Coffee break

10:00 – 10:30
The nuts and bolts of immunotherapy: victories and challenges.
prof. dr. Evelien Smits
Center for Oncological Research
University of Antwerp
Antwerp, Belgium

10:30 – 11:15
Potential of molecular imaging to select patients for immunotherapy in cancer.
prof. dr. Egbert F. Smit
Thoracic Oncology Service
Netherlands Cancer Institute
Amsterdam, The Netherlands

Coffee break

11:45 – 12:30
Cancer immunotherapy treatment response criteria in clinical practice and imaging hallmarks of treatment toxicity.
dr. Egesta Lopci
Nuclear Medicine Department
Humanitas Clinical and Research Hospital
Milan, Italy